Drug intelligence / Profile preview

N-hydroxydansylamide

Development stage
Preclinical
Lead developer
Lodz University of Technology
Modality
Small Molecules
01

Overview

N-hydroxydansylamide (DAN-HNO) is a profluorescent azanone (nitroxyl, HNO) donor developed for the real-time visualization of HNO release and the study of HNO biology. Under physiological conditions (37°C, pH 7.4), N-hydroxydansylamide decomposes with a half-life of approximately 20 to 33 minutes to release a molecule of HNO and a fluorescent dansyl-based sulfinate derivative, allowing fluorometric monitoring of HNO release without depleting the HNO source. In vitro studies have demonstrated that HNO released from N-hydroxydansylamide exhibits potent antithrombotic activity by concentration-dependently inhibiting coagulation and activating fibrinolysis, potentially through the inhibition of platelet activity and fibrin polymerization.

02

Targets

CA2 (Carbonic Anhydrase 2)

Beyond the preview

Go deeper on N-hydroxydansylamide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on N-hydroxydansylamide.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call